Answers are grounded in this paper and cite their sources.
Free cholesterol (FC) flux between HDL and macrophages switches from efflux to influx as HDL-particle number (HDL-P) and mol% FC increase. Among normolipidemic subjects, ASCVD is more prevalent among patients with HDL that are dysfunctional acceptors of macrophage-FC efflux and among patients with a very high plasma HDL concentration, i.e., hyperalphalipoproteinemia. HDL receptor deficient mice (Scarb1 -/- ), a robust model of hyperalphalipoproteinemia, are ASCVD-susceptible. Scarb1 -/- and wild-type mouse HDL are equally good acceptors of macrophage-FC efflux but Scarb1 -/- HDL are more potent donors of FC influx . This provoked our hypothesis that high HDL-FC bioavailability = HDL-P x HDL-mol% FC is associated with excess human ASCVD. Here we describe assay-validation for HDL-FC influx into macrophages and transfer to LDL. Methods: HDL-[ 3 H]FC Transfer to J774 Macrophages: HDL-[ 3 H]FC from five volunteers were co-incubated with cells for 2 h at 37°C, cells were washed, lipid-extracted, and the extract β-counted. Influx was expressed as pmol FC uptake/mg cell-protein. HDL-[ 3 H]FC Transfer to LDL: LDL and HDL-[ 3 H]FC, each at 0.5 mg protein/mL, were co-incubated for 2 h at 37°C and remaining HDL-associated FC was determined. FC transfer was expressed as pmol FC transferred to LDL. Results: Within-day and day-to-day CVs for FC transfer to LDL were 2.5% and 2.0%, and for influx, 4.3% and 10.7%. HDL-mol % FC and nmol FC/mg protein differed among five donors and correlated with the donor LDL-FC content. HDL-FC transfer to LDL and macrophages increased linearly with HDL-mol% FC. HDL-FC transfer to LDL correlated with influx to macrophages (Figure). Conclusions: Among putatively normolipidemic blood donors, HDL-FC content varies. This is associated with similar variations in HDL-mol% FC, FC transfer to LDL and FC influx to cells. HDL-FC transfer to LDL is a good surrogate of macrophage influx. These assays will be used to determine if a high HDL-FCBI correlates with human ASCVD.
No takes yet. Share an insight, caveat, or question.
Gillard et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: